Overexpression of GPNMB Predicts an Unfavorable Outcome of Epithelial Ovarian Cancer

Rui-qiong Ma,Zhi-jian Tang,Xue Ye,Hong-yan Cheng,Kun-kun Sun,Xiao-hong Chang,Heng Cui
DOI: https://doi.org/10.1007/s00404-018-4699-3
2018-01-01
Archives of Gynecology and Obstetrics
Abstract:Glycoprotein non-metastatic protein B (GPNMB) is a transmembrane glycoprotein that is expressed at higher levels in several malignant human tissues than those in matched normal tissues. Thus, GPNMB may serve as an attractive therapeutic target of cancer treatment. In this study, the prognostic value of GPNMB expression was examined in tumors derived from a cohort of patients with epithelial ovarian cancer (EOC).
What problem does this paper attempt to address?